Team:TecMonterrey

From 2013.igem.org

(Difference between revisions)
Line 4: Line 4:
<h2><b>Project description</b></h2>
<h2><b>Project description</b></h2>
-
It has been shown that certain strains of bacteria such as Escherichia coli, Salmonella, and Clostridium selectively colonize and grow in tumors and a number of reports have demonstrated that bacteria are capable of targeting both primary tumors and metastases.
+
It has been shown that certain strains of bacteria such as Escherichia coli, Salmonella, and Clostridium selectively colonize and grow in tumors and a number of reports have demonstrated that some bacteria are capable of targeting both primary tumors and metastases.
By exploiting this inherent ability of E. coli, this project aims to combine 3 different approaches in one bacterial system: the development of an E. coli capable of producing two cancer-specific apoptosis inducing proteins, a secretion system for the delivery of therapeutic proteins, and the design of a control mechanism confining the production of the therapeutic proteins only in tumor-specific regions.
By exploiting this inherent ability of E. coli, this project aims to combine 3 different approaches in one bacterial system: the development of an E. coli capable of producing two cancer-specific apoptosis inducing proteins, a secretion system for the delivery of therapeutic proteins, and the design of a control mechanism confining the production of the therapeutic proteins only in tumor-specific regions.

Revision as of 02:16, 10 August 2013

Project description

It has been shown that certain strains of bacteria such as Escherichia coli, Salmonella, and Clostridium selectively colonize and grow in tumors and a number of reports have demonstrated that some bacteria are capable of targeting both primary tumors and metastases.

By exploiting this inherent ability of E. coli, this project aims to combine 3 different approaches in one bacterial system: the development of an E. coli capable of producing two cancer-specific apoptosis inducing proteins, a secretion system for the delivery of therapeutic proteins, and the design of a control mechanism confining the production of the therapeutic proteins only in tumor-specific regions.

TecMonterrey logo.png
iGEM TecMonterrey Team
Team TecMonterrey


Home Team Official Team Profile Project Parts Submitted to the Registry Modeling Notebook Safety Attributions